MindBio Therapeutics CEO Discusses AI Voice Detection Platform in TechMediaWire Podcast
May 12th, 2026 2:05 PM
By: Newsworthy Staff
MindBio Therapeutics CEO Justin Hanka appeared on the TechMediaWire Podcast to discuss the company’s AI-driven voice analysis technology for detecting drug and alcohol intoxication, which aims to improve safety in regulated workplaces such as mining.

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Founder and CEO Justin Hanka joined the latest episode of the TechMediaWire Podcast to discuss the company’s artificial intelligence-driven voice analysis technology designed to detect drug and alcohol intoxication through noninvasive speech analysis. During the interview, Hanka outlined the limitations of traditional testing methods and described MindBio’s commercial focus on regulated workplace environments such as mining, where the company believes its scalable detection platform could improve safety by expanding real-time intoxication screening capabilities.
The technology leverages over 50 million data points to predict alcohol intoxication with remarkable accuracy, using only the human voice. MindBio is developing an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for detection in various industries, including mining, aviation, construction, and law enforcement. This noninvasive approach addresses the shortcomings of conventional methods like breathalyzers or urine tests, which can be cumbersome, time-consuming, or invasive.
The podcast appearance highlights MindBio’s strategy to commercialize its AI prediction technologies for drug and alcohol intoxication detection. The company believes that its voice analysis platform can significantly enhance workplace safety by enabling rapid, scalable, and real-time screening. This is particularly relevant in high-risk sectors where impairment can lead to accidents and fatalities.
The full press release discussing this development is available at https://ibn.fm/SU3Ay. For more information about MindBio Therapeutics, including the latest news and updates, visit the company’s newsroom at https://ibn.fm/MBQIF.
This announcement underscores the growing intersection of artificial intelligence and occupational health, with MindBio positioning itself as a pioneer in voice-based intoxication detection. As regulatory scrutiny around workplace safety intensifies, such technologies could become integral to corporate risk management strategies.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
